<Disease><Name>THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2</Name><Synonym>ENCEPHALOPATHY, THIAMINE-RESPONSIVE, BTBGD; SLC19A3</Synonym><OMIM><Number>607483</Number><URL>http://omim.org/entry/607483</URL></OMIM><Orphanet><Number>65284</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=65284</URL></Orphanet><Protein><Number>Thiamine transporter 2</Number><URL>http://www.uniprot.org/uniprot/Q9BZV2</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>2q36.3</Gene><ICD>G93.8</ICD><Summary>rare;autosomal recessive;mutation in the SLC19A3 gene</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2363</id><symptom>basal ganglia, changes, lesions, calcifications (MRI, CT)</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2163</id><symptom>dysphagia</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4107</id><symptom>Encephalopathic crisis, acute</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3197</id><symptom>lactic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2479</id><symptom>MRS, brain, abnormalities / Magnetic resonance spectroscopy (MRS)</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3783</id><symptom>onset, variable age</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2339</id><symptom>ophthalmoplegia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2170</id><symptom>weight loss</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2048</id><name>Sedoheptulose-7-phosphate</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.07</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>452</id><name>2,4-Dihydroxybutyric acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>7.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>455</id><name>2,4-Dihydroxybutyric acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.00</min><max>260.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1336</id><name>2,4-Dihydroxybutyric acid</name><specimen>urine</specimen><value>normal/inc</value><min>2.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1337</id><name>2,4-Dihydroxybutyric acid</name><specimen>urine</specimen><value>normal/inc</value><min>24.00</min><max>93.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>1338</id><name>2,4-Dihydroxybutyric acid</name><specimen>urine</specimen><value>normal/inc</value><min>11.90</min><max>179.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>77</id><name>2-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>352</id><name>2-Hydroxyisovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>18.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>353</id><name>2-Hydroxyisovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit /><age>adult</age><method /><comment /></metabolite><metabolite><id>1319</id><name>2-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1711</id><name>2-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>767</id><name>L-Lactic acid</name><specimen>jejunal biopsy</specimen><value>increased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>21</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>3.50</min><max>29.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>536</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>197.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>537</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>40.00</min><max>326.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>538</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>117.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>539</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>64.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1411</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>100.00</min><max>152.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>330</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>3.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>339</id><name>L-Lactic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.50</min><max>1.80</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>469</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>208</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>211</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>214</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>1.00</min><max>2.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>206</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.90</min><max>2.00</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>209</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.50</min><max>1.60</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>212</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.60</min><max>0.90</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>202</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>210</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>213</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.40</min><max>1.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1137</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.40</min><max>0.90</max><unit>mmol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>1136</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.60</max><unit>mmol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>203</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>204</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>1.00</min><max>1.50</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>207</id><name>L-Lactic acid</name><specimen>blood</specimen><value>increased</value><min>2.00</min><max>3.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1813</id><name>L-Lactic acid</name><specimen>urine</specimen><value>increased</value><min>45.00</min><max>410.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite></Metabolites><Literatures><literature><id>6755</id><title>Biotin-Thiamine Responsive Encephalopathy: Report of an Egyptian Family with a Novel SLC19A3 Mutation and Review of the Literat</title><author>Savasta S,</author><journal>J Pediatr Genet</journal><year>2019</year><book /><volume>8</volume><number>2</number><pages>100-108</pages><co_aut>et al.</co_aut></literature><literature><id>6788</id><title>Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics and functional studies</title><author>Marce-Grau A,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6756</id><title>Biotin-Thiamine-Responsive Basal Ganglia Disease-A Treatable Metabolic Disorder</title><author>Mir A,</author><journal>Pediatr Neurol</journal><year>2018</year><book /><volume>87</volume><number>0</number><pages>80-81</pages><co_aut>Alhazmi R2, Albaradie R</co_aut></literature><literature><id>6757</id><title>Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?</title><author>Kamasak T,</author><journal>Eur J Paediatr Neurol</journal><year>2018</year><book /><volume>22</volume><number>6</number><pages>1139-1149</pages><co_aut>et al.</co_aut></literature><literature><id>5299</id><title>High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice</title><author>Suzuki K,</author><journal>PLoS One</journal><year>2017</year><book /><volume>12</volume><number>6</number><pages>e0180279</pages><co_aut>et al.</co_aut></literature><literature><id>5300</id><title>Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SL</title><author>Ferreira CR,</author><journal>Am J Med Genet A</journal><year>2017</year><book /><volume>173</volume><number>6</number><pages>1502-1513</pages><co_aut>Whitehead MT, Leon E</co_aut></literature><literature><id>5301</id><title>Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment</title><author>Algahtani H,</author><journal>Neurol Res</journal><year>2017</year><book /><volume>39</volume><number>2</number><pages>117-125</pages><co_aut>et al.</co_aut></literature><literature><id>6753</id><title>Case 38-2017. A 20-Year-Old Woman with Seizures and Progressive Dystonia</title><author>Eichler FS,</author><journal>N Engl J Med</journal><year>2017</year><book /><volume>377</volume><number>24</number><pages>2376-2385</pages><co_aut>et al.</co_aut></literature><literature><id>5302</id><title>A case report of biotin-thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended?</title><author>Aljabri MF,</author><journal>Medicine (Baltimore)</journal><year>2016</year><book /><volume>95</volume><number>40</number><pages>e4819</pages><co_aut>et al.</co_aut></literature><literature><id>5303</id><title>Thiamine transporter-2 deficiency: outcome and treatment monitoring</title><author>Ortigoza-Escobar JD,</author><journal>Orphanet J Rare Dis</journal><year>2014</year><book /><volume>9</volume><number>0</number><pages>92</pages><co_aut>et al.</co_aut></literature><literature><id>6754</id><title>Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy</title><author>Kevelam SH,</author><journal>Brain</journal><year>2013</year><book /><volume>136</volume><number>5</number><pages>1534-1543</pages><co_aut>et al.</co_aut></literature><literature><id>5298</id><title>Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations</title><author>Debs R,</author><journal>Arch Neurol</journal><year>2010</year><book /><volume>67</volume><number>1</number><pages>126-130</pages><co_aut>et al.</co_aut></literature><literature><id>5297</id><title>Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3</title><author>Zeng WQ,</author><journal>Am J Hum Genet</journal><year>2005</year><book /><volume>77</volume><number>1</number><pages>16-26</pages><co_aut>et al.</co_aut></literature><literature><id>5296</id><title>Biotin-responsive basal ganglia disease: a novel entity</title><author>Ozand PT,</author><journal>Brain</journal><year>1998</year><book /><volume>121</volume><number>7</number><pages>1267-1279</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>